Centre actions to press cost effective generic drugs assist Jan Aushadhi shops cross sales target

The Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) that offers inexpensive generic medications through Jan Aushadhi Kendras (retail outlets) stated it has actually attained sales of 1,236 crore in FY23, growing 38% year-on-year. In FY22, the turnover was 893 crore. “We have actually crossed the 1,200-crore modified target set by the federal government; the initial target based on the five-year strategy for the plan was 775 crore,” stated Ravi Dadhich, CEO of the Pharmaceuticals & Medical Devices Bureau of India (PMBI), the company under ministry of chemical & fertilisers that executes PMBJP. Dadhich associated the development in sales to a number of efforts taken in the last 2 years consisting of increasing the variety of Jan Aushadhi Kendras, guaranteeing enough schedule of medications, and substantial promotion offered to the plan by the Prime Minister and other cabinet ministers. Far, the federal government has actually operationalised 9,300 Jan Aushadhi Kendras with items making up 1,800 lifesaving medications and 285 surgical, nutraceuticals and medical gadgets, at 50-90% less expensive than the top quality ones. The Jan Aushadhi Kendras or shops are run by little business owners. PMBI acquires medications by drifting tenders, and materials these medications to the shops through its storage facilities. “We have a target to increase the variety of kendras to 10,000 in FY24,” Dadhich stated. The federal government has
Find out more